Ideation Analytics 3.0 is a major update to Discngine's Structure-Activity Relationship (SAR) analysis and reporting platform. Alongside new enterprise-level collaboration and dataset management capabilities, the release extends support to peptide SAR analysis and reporting workflows. Read the full article to learn more about what's new in Ideation Analytics 3.0.

On the Crinetics Therapeutics’ recently approved drug example we performed retroactive study with Ideation Analytics, showing how it supports patent exploration through efficient functionality and high-quality visualizations that follow medicinal chemists' workflows.

During lead optimization, SAR analysis drives compound design, while patent data provides context on prior art. These perspectives are often reviewed separately, making early decisions harder. This article looks at how bringing them together in a single workflow with tools such as Discngine Ideation Analytics, reduces rework and guides more confident design choices.

Manual structure-activity relationship (SAR) reporting is a time-consuming, tedious, and repetitive task.

To regain time from data wrangling, Discngine has developed Ideation Analytics- an automated platform for SAR reporting and analysis.

To streamline the Structure-Activity Relationship (SAR) exploration of patents, it is now possible to access GOSTAR™ patent datasets directly within Ideation SAR Slides.